Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
IQV
Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV) StockStory - Wed Apr 1, 10:32PM CDT

Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV)

IQV : 172.19 (+2.90%)
QRVO
3 Profitable Stocks with Questionable Fundamentals StockStory - Wed Mar 25, 11:36PM CDT

3 Profitable Stocks with Questionable Fundamentals

PEP : 156.01 (-0.67%)
QRVO : 79.65 (-0.20%)
IQV : 172.19 (+2.90%)
Charles River Laboratories International Inc_ chart and logo-by IgorGolovniov via Shutterstock
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? Barchart - Mon Mar 23, 6:32PM CDT

While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

XLV : 146.89 (-0.29%)
CRL : 179.59 (+2.24%)
IQV : 172.19 (+2.90%)
LH
3 Value Stocks We Steer Clear Of StockStory - Thu Mar 19, 11:32PM CDT

3 Value Stocks We Steer Clear Of

LH : 262.47 (+0.59%)
FBRT : 8.68 (+0.12%)
IQV : 172.19 (+2.90%)
ACM
3 Mid-Cap Stocks We Keep Off Our Radar StockStory - Wed Mar 18, 4:39AM CDT

3 Mid-Cap Stocks We Keep Off Our Radar

ACM : 84.79 (+1.44%)
BLD : 397.12 (+0.70%)
IQV : 172.19 (+2.90%)
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences Business Wire - Mon Mar 16, 3:30PM CDT

IQVIA Holdings Inc. (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced at NVIDIA GTC the launch of ...

IQV : 172.19 (+2.90%)
KO
1 S&P 500 Stock Worth Your Attention and 2 We Question StockStory - Wed Mar 11, 11:31PM CDT

1 S&P 500 Stock Worth Your Attention and 2 We Question

KO : 75.96 (-1.95%)
BMY : 57.67 (-1.62%)
IQV : 172.19 (+2.90%)
IQVIA Holdings Inc logo on phone-by Piotr Swat via Shutterstock
Is IQVIA Holdings Stock Underperforming the Nasdaq? Barchart - Tue Mar 10, 9:01AM CDT

IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

A : 116.73 (+1.45%)
$NASX : 23,024.54 (+0.53%)
IQV : 172.19 (+2.90%)
IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference Business Wire - Mon Mar 2, 3:30PM CST

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 172.19 (+2.90%)
IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference Business Wire - Mon Mar 2, 3:15PM CST

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 172.19 (+2.90%)

Barchart Exclusives

Michael Burry is Loading Up on JD.com Stock. Should You? Barchart - Mon Apr 13, 9:22AM CDT
Michael Burry just added JD.com stock to his portfolio, calling recent weakness "an attractive entry point." Here's what the numbers say and whether you should follow his move. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.